Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Acacia Pharma Ltd.

Home Clinical Trial Sponsors and OrganizationsAcacia Pharma Ltd.

Acacia Pharma Ltd.

ACTIVE

United Kingdomwww.acaciapharma.comSubsidiary51–100 employeesEstablished: 2006-01-01

Part of Acacia Pharma Group Ltd.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

31

14 active

Approvals

4

Total approvals

Agencies

1

Regulatory bodies

Founded

2006

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

12

38.7%

Phase 2

7

22.6%

Phase 3

6

19.4%

Trial Status Distribution

Active, not recruiting

14

45.2%

Completed

16

51.6%

Withdrawn

1

3.2%

Clinical Trials

Trials sponsored by this organization (31)

Post Operative Nausea and Vomiting (PONV) Rescue Outcomes After Amisulpride Treatment

Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures

Active, not recruiting

Nov 2021100 participants

PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment

Jun 202112 participants

Study of APD421 With and Without Ondansetron

Jul 201830 participants

Mass-balance Study of [14C]-APD421 in Healthy Volunteers

Aug 20166 participants

Study of APD421 as PONV Treatment (Prior Prophylaxis)

Mar 2016705 participants

Clinical trial to compare APD421 (amisulpride) against a placebo for the treatment of patients feeling sick or being sick after an operation, who have previously been given preventative anti-sickness medicine.

Active, not recruiting

Dec 2015700 participants

Study of APD421 as PONV Treatment (no Prior Prophylaxis)

Sep 2015568 participants

Page 1 of 4

Approvals

Approvals by Agency

FDA

Food and Drug Administration

4

Approvals

Recent Approvals

News

No news articles found

On this page

Overview
Clinical Trials31
Approvals4
News

Back to Organizations